HRT Financial’s HUMANIGEN, INC. HGEN Stock Holding History

HRT Financial’s Portfolio HGEN Stock Details HGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-16,469	Closed	-$2K	–	3414
2023 Q2	$2K	Sell	16,469 -9,639	-37%	-$1.5K	﹤0.01%	2309
2023 Q1	$3K	Buy	+26,108	New	+$4.18K	﹤0.01%	2338
2022 Q3	–	Sell	-37,340	Closed	-$66K	–	3747
2022 Q2	$66K	Buy	+37,340	New	+$83.8K	﹤0.01%	2484
2022 Q1	–	Sell	-428,124	Closed	-$1.59M	–	4112
2021 Q4	$1.59M	Buy	+428,124	New	+$2.5M	0.01%	788
2021 Q2	–	Sell	-162,373	Closed	-$3.1M	–	3735
2021 Q1	$3.1M	Buy	+162,373	New	+$2.96M	0.03%	416

Other funds holding HGEN

TCM

Triumph Capital Management Denver, Colorado $552M AUM 20.75% 1-Year Est. Return

DWP

Daymark Wealth Partners Cincinnati, Ohio $3.18B AUM 23.46% 1-Year Est. Return

CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return

HRT Financial's HGEN Position: Q3 2023 in Review

HRT Financial sold out of HUMANIGEN, INC. (HGEN) in Q3 2023, closing a stake of 16,469 shares — an estimated $2K sold.

HRT Financial first reported a position in HGEN in Q1 2021 and held it in 5 quarters. The position peaked at $3.1M in Q1 2021. 3 funds tracked by Wall St. Rank hold HGEN as of Q3 2023.

HRT Financial reported no remaining HUMANIGEN, INC. position as of Q3 2023 after selling out during the quarter.
HRT Financial sold 16,469 HUMANIGEN, INC. shares in Q3 2023, an estimated $2K.
HRT Financial first reported a position in HUMANIGEN, INC. in Q1 2021 and held it in 5 quarters.
HRT Financial's HUMANIGEN, INC. position peaked at $3.1M in Q1 2021.
3 funds tracked by Wall St. Rank held HUMANIGEN, INC. as of Q3 2023.

Based on HRT Financial's 13F filing for Q3 2023, filed 13 Nov 2023.